1 - 25 of 115 results for author:"Heldin C.H." in Literature citations
Results Customize
› Repeat search in UniProtKB (61)
| Regulation of EMT by TGFbeta in cancer. Heldin C.H., Vanlandewijck M., Moustakas A. FEBS Lett. 586:1959-1970(2012) · Mapped (9) |
| APC and Smad7 link TGFbeta type I receptors to the microtubule system to promote cell migration. Ekman M., Mu Y., Lee S.Y., Edlund S., Kozakai T., Thakur N., Tran H., Qian J., Groeden J., Heldin C.H. et al. Mol. Biol. Cell 23:2109-2121(2012) · Mapped (17) |
| Transcriptional induction of salt-inducible kinase 1 by transforming growth factor beta leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligase. Lonn P., Vanlandewijck M., Raja E., Kowanetz M., Watanabe Y., Kowanetz K., Vasilaki E., Heldin C.H., Moustakas A. J. Biol. Chem. 287:12867-12878(2012) · Mapped (12) |
| Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. Tan E.J., Thuault S., Caja L., Carletti T., Heldin C.H., Moustakas A. J. Biol. Chem. 287:7134-7145(2012) · Mapped (4) |
| Polyubiquitination of transforming growth factor beta (TGFbeta)-associated kinase 1 mediates nuclear factor-kappaB activation in response to different inflammatory stimuli. Hamidi A., von Bulow V., Hamidi R., Winssinger N., Barluenga S., Heldin C.H., Landstrom M. J. Biol. Chem. 287:123-133(2012) · Mapped (15) |
| TRAF6 ubiquitinates TGFbeta type I receptor to promote its cleavage and nuclear translocation in cancer. Mu Y., Sundar R., Thakur N., Ekman M., Gudey S.K., Yakymovych M., Hermansson A., Dimitriou H., Bengoechea-Alonso M.T., Ericsson J. et al. Nat Commun 2:330-330(2011) · Mapped (5) |
| The LAR protein tyrosine phosphatase enables PDGF beta-receptor activation through attenuation of the c-Abl kinase activity. Zheng W., Lennartsson J., Hendriks W., Heldin C.H., Hellberg C. Cell. Signal. 23:1050-1056(2011) · Mapped (6) |
| Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-beta phosphorylation, and microvessel density in gastric cancer. Suzuki S., Dobashi Y., Hatakeyama Y., Tajiri R., Fujimura T., Heldin C.H., Ooi A. BMC Cancer 10:659-659(2010) · Mapped (14) |
| PARP-1 attenuates Smad-mediated transcription. Lonn P., van der Heide L.P., Dahl M., Hellman U., Heldin C.H., Moustakas A. Mol. Cell 40:521-532(2010) · Mapped (18) |
| Negative regulation of TGFbeta signaling by the kinase LKB1 and the scaffolding protein LIP1. Moren A., Raja E., Heldin C.H., Moustakas A. J. Biol. Chem. 286:341-353(2011) · Mapped (12) |
| The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. Karousou E., Kamiryo M., Skandalis S.S., Ruusala A., Asteriou T., Passi A., Yamashita H., Hellman U., Heldin C.H., Heldin P. J. Biol. Chem. 285:23647-23654(2010) · Mapped (1) |
| Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration. Wardega P., Heldin C.H., Lennartsson J. Cell. Signal. 22:1363-1368(2010) · UniProtKB (6) |
| Smad7 regulates the adult neural stem/progenitor cell pool in a transforming growth factor beta- and bone morphogenetic protein-independent manner. Krampert M., Chirasani S.R., Wachs F.P., Aigner R., Bogdahn U., Yingling J.M., Heldin C.H., Aigner L., Heuchel R. Mol. Cell. Biol. 30:3685-3694(2010) · Mapped (4) |
| Filamin a mediates HGF/c-MET signaling in tumor cell migration. Zhou A.X., Toylu A., Nallapalli R.K., Nilsson G., Atabey N., Heldin C.H., Boren J., Bergo M.O., Akyurek L.M. Int. J. Cancer 128:839-846(2011) · Mapped (11) |
| Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. Cunha S.I., Pardali E., Thorikay M., Anderberg C., Hawinkels L., Goumans M.J., Seehra J., Heldin C.H., ten Dijke P., Pietras K. J. Exp. Med. 207:85-100(2010) · Mapped (9) |
| Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Paulsson J., Sjoblom T., Micke P., Ponten F., Landberg G., Heldin C.H., Bergh J., Brennan D.J., Jirstrom K., Ostman A. Am. J. Pathol. 175:334-341(2009) · Mapped (4) |
| Functional role of Meox2 during the epithelial cytostatic response to TGF-beta. Valcourt U., Thuault S., Pardali K., Heldin C.H., Moustakas A. Mol Oncol 1:55-71(2007) · Mapped (16) |
| Activation of protein kinase C alpha is necessary for sorting the PDGF beta-receptor to Rab4a-dependent recycling. Hellberg C., Schmees C., Karlsson S., Ahgren A., Heldin C.H. Mol. Biol. Cell 20:2856-2863(2009) · Mapped (11) |
| Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation. Jurek A., Amagasaki K., Gembarska A., Heldin C.H., Lennartsson J. J. Biol. Chem. 284:4626-4634(2009) · Mapped (4) |
| HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. Thuault S., Tan E.J., Peinado H., Cano A., Heldin C.H., Moustakas A. J. Biol. Chem. 283:33437-33446(2008) · Mapped (5) |
| Nck adapters are involved in the formation of dorsal ruffles, cell migration, and Rho signaling downstream of the platelet-derived growth factor beta receptor. Ruusala A., Pawson T., Heldin C.H., Aspenstrom P. J. Biol. Chem. 283:30034-30044(2008) · Mapped (10) |
| A gain-of-function mutation in the PDGFR-beta alters the kinetics of injury response in liver and skin. Krampert M., Heldin C.H., Heuchel R.L. Lab. Invest. 88:1204-1214(2008) · Mapped (7) |
| The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Sorrentino A., Thakur N., Grimsby S., Marcusson A., von Bulow V., Schuster N., Zhang S., Heldin C.H., Landstrom M. Nat. Cell Biol. 10:1199-1207(2008) · UniProtKB (3) · Mapped (7) |
| TGFbeta induces SIK to negatively regulate type I receptor kinase signaling. Kowanetz M., Lonn P., Vanlandewijck M., Kowanetz K., Heldin C.H., Moustakas A. J. Cell Biol. 182:655-662(2008) · Mapped (1) |
| A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Rosengren Pielberg G., Golovko A., Sundstrom E., Curik I., Lennartsson J., Seltenhammer M.H., Druml T., Binns M., Fitzsimmons C., Lindgren G. et al. Nat. Genet. 40:1004-1009(2008) · UniProtKB (5) |